Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
25.04
0.07 (0.28%)
At close: Aug 15, 2025, 3:59 PM
25.11
0.30%
After-hours: Aug 15, 2025, 04:34 PM EDT

Janux Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-41.71 -8.1 -8.66 -24.99
PEG Ratio
13.76 0.62 -0.09 -0.06
PS Ratio
271.80 58.43 63.42 223.74
PB Ratio
2.81 1.37 1.70 2.22
P/FCF Ratio
-65.15 -9.01 -11.06 -44.09
P/OCF Ratio
-65.68 -9.34 -12.72 -47.93
OCF/S Ratio
-4.14 -6.26 -4.98 -4.67
Debt / Equity Ratio
0.02 0.07 0.08 0.00
Quick Ratio
59.21 26.80 20.18 29.48
Current Ratio
59.21 26.80 20.14 29.46
Asset Turnover
0.01 0.02 0.02 0.01
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.07 -0.17 -0.2 -0.09
Return on Assets
-0.06 -0.15 -0.17 -0.09
Return on Invested Capital
-0.09 -0.2 -0.19 -0.09
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.81 0.76 0.90 0.97
Net Profit Margin
-6.52 -7.21 -7.32 -8.95
Pretax Profit Margin
-6.52 -7.21 -7.32 -8.98
Operating Profit Margin
-9.34 -9.03 -7.79 -9.05
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-9.34 -8.79 -7.69 -9.02